Acute Myeloid Leukemia
Many questions about AML remain unanswered, and controversy continues
Published in Blood Weekly, September 23rd, 2004
According to a study from Italy, "Acute myeloid leukemia is a heterogeneous disease that presents with a range of morphological, cytogenetic, immunophenotypic, and biomolecular features. Over the past 20 years, application of new cytogenetic and molecular techniques has greatly improved knowledge of the pathophysiology of AML, resulting in new potential therapeutic applications."
"However," noted F. Ferrara, Cardarelli General Hospital, Naples, "the results of current therapy are still unsatisfactory, especially in patients who have adverse prognostic...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-09-23)
More Articles from Blood Weekly
- Bacterial Detection
Novel assay improves detection rate of diarrhea-causing bacteria in stool - Blood Safety
U.S. Dept. of Defense funds Mirasol Pathogen Reduction Technology development - Blood Substitute
Blood substitute developer receives funding from Defense Appropriations Bill - Diagnostics
Serum procalcitonin more accurate than CRP as marker of bacterial infection - Stem Cell Transplantation
Neural stem cell transplants improve motor function in Huntington disease - Angiology
Promising new anticoagulant offers fibrin-targeted factor Xa inhibition - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
